Pathogenic Mechanisms of HHV-8 ORF74
Pathogenic Mechanisms of HHV-8 ORF74
批准号:
6695201
负责人:
MARVIN S REITZ
金额:
$29.74万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-06-30
关键词:
Kaposi's sarcoma apoptosis cell adhesion molecules cell line cellular oncology cytokine receptors human herpesvirus 8 human immunodeficiency virus 1 laboratory mouse luciferin monooxygenase neoplastic growth oncoproteins open reading frames phosphatidylinositol 3 kinase phosphorylation protein protein interaction serine threonine protein kinase transcription factor transfection viral carcinogenesis virus infection mechanism virus protein virus related neoplasm /cancer virus virus interaction
中文摘要
描述(由申请人提供):
大量证据表明人类疱疹病毒8型(HHV-8),也称为卡波西肉瘤疱疹病毒(KSHV),是卡波西肉瘤(KS)的必要病原体。虽然KS发病机制的HHV-8还没有很好地理解,最近的证据表明,表达的旁分泌因子细胞裂解期病毒复制是很重要的。HHV-8趋化因子受体同源物ORF 74是一种裂解期基因产物,在没有添加配体的情况下激活几种信号传导途径,包括NF κ B、NF-AT和AP-1,并诱导促炎细胞因子和细胞粘附分子的表达。我们假设NF κ B、NF-AT和AP-1的激活依赖于通过PI-3激酶-Akt通路的信号传导,并导致促炎因子的表达,并且这些因子的慢性失调表达最终导致肿瘤形成。合并感染HIV-1是KS发展的一个非常强的风险因素。我们推测HIV-1的达特蛋白与ORF 74协同作用,通过PI-3激酶-Akt通路激活NF κ B、NF-AT和AP-1,并增强ORF 74介导的肿瘤发生。中心假设是Akt是这些ORF 74依赖性过程的关键介质。为了检验这些假设,我们将表征NF κ B、NF-AT和AP-1的ORF 74激活以及通过PI-3激酶-Akt诱导促炎和抗凋亡因子,并将确定小鼠模型中ORF 74介导的肿瘤发生是否依赖于通过PI-3激酶-Akt和GSK-3激活NF κ B、NFAT和AP-1。我们还将确定达特是否通过PI-3激酶-Akt和GSK-3增强NF κ B、NF-AT和AP-1的ORF 74活化,并增强小鼠中的ORF 74肿瘤发生。这些研究将为ORF 74对KS发病机制的贡献提供有价值的见解,并显示HIV-1与HHV-8合作导致KS的机制。
英文摘要
DESCRIPTION (provided by applicant):
Considerable evidence implicates human herpesvirus 8 (HHV-8), also known as Kaposi's sarcoma herpesvirus (KSHV), as the necessary etiologic agent of Kaposi's sarcoma (KS). Although the mechanisms of KS pathogenesis by HHV-8 are not well understood, recent evidence suggests that expression of paracrine factors by cells undergoing lytic phase viral replication is important. The HHV-8 chemokine receptor homologue ORF74, a lytic phase gene product, activates several signaling pathways in the absence of added ligand, including NFkB, NF-AT and AP-1, and induces the expression of pro-inflammatory cytokines and cell adhesion molecules. We hypothesize that activation of NFkappaB, NF-AT and AP-1 depends on signaling via the PI-3 kinase-Akt pathway and causes the expression of pro-inflammatory factors, and that chronic dysregulated expression of these factors eventually results in tumor formation. Co-infection with HIV-1 is an extremely strong risk factor for KS development. We hypothesize that the Tat protein of HIV-1 synergizes with ORF74 in activating NFkappaB, NF-AT and AP-1 through the PI-3 kinase-Akt pathway and enhances ORF74-mediated tumorigenesis. The central hypothesis is that Akt is the key mediator of these ORF74-dependent processes. To test these hypotheses, we will characterize ORF74 activation of NFKappaB, NF-AT and AP-1 and induction of pro-inflammatory and anti-apoptotic factors via PI-3 kinase-Akt and will determine whether ORF74-mediated tumorigenesis in a mouse model depends on activation of NFkappaB, NFAT and AP-1 via PI-3 kinase-Akt and GSK-3. We will also determine whether Tat augments ORF74 activation of NFkappaB, NF-AT and AP-1 via PI-3 kinase-Akt and GSK-3 and enhances ORF74 tumorigenesis in mice. These studies should provide valuable insights on the contribution of ORF74 to KS pathogenesis and show a mechanism by which HIV-1 cooperates with HHV-8 in causing KS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of Ritonavir on HHV-8 vGPCR signaling and tumorigenesis
-
批准号:7491371
-
项目类别:
-
资助金额:$13.84万
-
财政年份:2006
-
负责人:MARVIN S REITZ
-
依托单位:
Effects of Ritonavir on HHV-8 vGPCR signaling and tumorigenesis
-
批准号:7163346
-
项目类别:
-
资助金额:$16.93万
-
财政年份:2006
-
负责人:MARVIN S REITZ
-
依托单位:
Pathogenic Mechanisms of HHV-8 ORF74
-
批准号:6913724
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2003
-
负责人:MARVIN S REITZ
-
依托单位:
Pathogenic Mechanisms of HHV-8 ORF74
-
批准号:6770183
-
项目类别:
-
资助金额:$29.74万
-
财政年份:2003
-
负责人:MARVIN S REITZ
-
依托单位:
Pathogenic Mechanisms of HHV-8 ORF74
-
批准号:7489138
-
项目类别:
-
资助金额:$28.19万
-
财政年份:2003
-
负责人:MARVIN S REITZ
-
依托单位:
Pathogenic Mechanisms of HHV-8 ORF74
-
批准号:7089023
-
项目类别:
-
资助金额:$29.04万
-
财政年份:2003
-
负责人:MARVIN S REITZ
-
依托单位:
Pathogenic Mechanisms of HHV-8 ORF74
-
批准号:7225500
-
项目类别:
-
资助金额:$0.29万
-
财政年份:2003
-
负责人:MARVIN S REITZ
-
依托单位:
HHV-8 AND KAPOSI'S SARCOMA
-
批准号:6311553
-
项目类别:
-
资助金额:$15.41万
-
财政年份:2000
-
负责人:MARVIN S REITZ
-
依托单位:
HHV-8 AND KAPOSI'S SARCOMA
-
批准号:6203470
-
项目类别:
-
资助金额:$15.41万
-
财政年份:1999
-
负责人:MARVIN S REITZ
-
依托单位:
CHEMOKINE RECEPTOR EXPRESSION IN LYMPHOCYTES
-
批准号:2887747
-
项目类别:
-
资助金额:$7.43万
-
财政年份:1998
-
负责人:MARVIN S REITZ
-
依托单位:
CHEMOKINE RECEPTOR EXPRESSION IN LYMPHOCYTES
-
批准号:2650111
-
项目类别:
-
资助金额:$7.45万
-
财政年份:1998
-
负责人:MARVIN S REITZ
-
依托单位:
CORE--VIROLOGY
-
批准号:6100237
-
项目类别:
-
资助金额:$9.44万
-
财政年份:1998
-
负责人:MARVIN S REITZ
-
依托单位:
HHV-8 AND KAPOSI'S SARCOMA
-
批准号:6103518
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:MARVIN S REITZ
-
依托单位:
HHV-6 IN AIDS--MECHANISMS OF CD4 GENE ACTIVATION
-
批准号:2423531
-
项目类别:
-
资助金额:$7.25万
-
财政年份:1997
-
负责人:MARVIN S REITZ
-
依托单位:
HHV-6 IN AIDS--MECHANISMS OF CD4 GENE ACTIVATION
-
批准号:2673090
-
项目类别:
-
资助金额:$7.25万
-
财政年份:1997
-
负责人:MARVIN S REITZ
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: